These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 17605105

  • 1. Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P.
    Neurochem Res; 2007 Oct; 32(10):1709-17. PubMed ID: 17605105
    [Abstract] [Full Text] [Related]

  • 2. Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.
    Tahirovic I, Sofic E, Sapcanin A, Gavrankapetanovic I, Bach-Rojecky L, Salkovic-Petrisic M, Lackovic Z, Hoyer S, Riederer P.
    J Neural Transm Suppl; 2007 Oct; (72):235-40. PubMed ID: 17982899
    [Abstract] [Full Text] [Related]

  • 3. Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.
    Sapcanin A, Sofic E, Tahirovic I, Salkovic-Petrisic M, Hoyer S, Riederer P.
    Neurotox Res; 2008 Apr; 13(2):97-104. PubMed ID: 18515212
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats.
    Jang YY, Song JH, Shin YK, Han ES, Lee CS.
    Pharmacol Res; 2000 Oct; 42(4):361-71. PubMed ID: 10987997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.
    Crunfli F, Mazucanti CH, de Moraes RCM, Costa AP, Rodrigues AC, Scavone C, Torrão AS.
    J Alzheimers Dis; 2018 Oct; 65(4):1427-1443. PubMed ID: 30149447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Establishment of a rat model of type II diabetic neuropathic pain.
    Dang JK, Wu Y, Cao H, Meng B, Huang CC, Chen G, Li J, Song XJ, Lian QQ.
    Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.
    Agrawal R, Tyagi E, Shukla R, Nath C.
    Neuropharmacology; 2009 Mar; 56(4):779-87. PubMed ID: 19705549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.